Human amniotic membrane allograft, a novel treatment for chronic diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials
- PMID: 32119765
- PMCID: PMC7949407
- DOI: 10.1111/iwj.13318
Human amniotic membrane allograft, a novel treatment for chronic diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials
Abstract
To evaluate the efficacy and safety of human amniotic membrane (HAM) allograft in treating chronic diabetic foot ulcers (DFUs), a comprehensive search of randomised controlled trials in MEDLINE, EMBASE, PubMed, CENTRAL and Web of Science was conducted to December 7, 2019. Two reviewers independently screened the studies, extracted data, and evaluated the quality of studies. The primary outcome was the proportion of complete healing. The secondary outcomes were mean time to complete healing and adverse events. Statistical analyses were performed using RevMan 5.3. We identified 257 articles, of which 7 articles (465 participants) were included in the meta-analysis. The proportion of complete wound healing in HAM plus standard of care (SOC) group was 3.88 times as high as that in SOC alone (RR: 3.88 [95% CI: 2.34, 6.44]) at 6 weeks, and 2.01 times at 12 weeks (RR: 2.01 [95%CI: 1.45, 2.77]). The intervention group had a significantly shorter time to complete healing (MD: -30.33 days, [95% CI: -37.95, -22.72]). The number needed to treat within 6 weeks was 2.3 ([95% CI: 1.8, 3.1]). No significant difference was shown in adverse events. Results were consistent in a sensitivity analysis. Hence, HAM plus SOC is effective and safe in treating chronic DFUs.
Keywords: diabetic foot ulcer; human amniotic membrane; meta-analysis; systematic review; wound closure.
© 2020 Medicalhelplines.com Inc and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures







Similar articles
-
Effectiveness and safety of human amnion/chorion membrane therapy for diabetic foot ulcers: An updated meta-analysis of randomized clinical trials.Wound Repair Regen. 2020 Nov;28(6):739-750. doi: 10.1111/wrr.12851. Epub 2020 Aug 11. Wound Repair Regen. 2020. PMID: 32715574
-
Evidence for Healing Diabetic Foot Ulcers With Biologic Skin Substitutes: A Systematic Review and Meta-Analysis.Ann Plast Surg. 2019 Oct;83(4S Suppl 1):S31-S44. doi: 10.1097/SAP.0000000000002096. Ann Plast Surg. 2019. PMID: 31513064
-
Biological effects of amniotic membrane on diabetic foot wounds: a systematic review.J Wound Care. 2018 Feb 1;27(Sup2):S19-S25. doi: 10.12968/jowc.2018.27.Sup2.S19. J Wound Care. 2018. PMID: 29419367
-
A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.Wounds. 2016 Mar;28(3):70-7. Wounds. 2016. PMID: 26978860 Clinical Trial.
-
Use of a dual-layer amniotic membrane in the treatment of diabetic foot ulcers: an observational study.J Wound Care. 2020 Sep 1;29(Sup9):S8-S12. doi: 10.12968/jowc.2020.29.Sup9.S8. J Wound Care. 2020. PMID: 32924804
Cited by
-
Evaluation of the effect of a gel made with amniotic fluid formulation on the healing of diabetic foot ulcers: A triple-blind clinical trial.Front Public Health. 2022 Dec 15;10:1025391. doi: 10.3389/fpubh.2022.1025391. eCollection 2022. Front Public Health. 2022. PMID: 36589960 Free PMC article. Clinical Trial.
-
Amniotic growth factors enhanced human pre-adipocyte cell viability and differentiation under hypoxia.J Biomed Mater Res B Appl Biomater. 2022 Sep;110(9):2146-2156. doi: 10.1002/jbm.b.35068. Epub 2022 Apr 6. J Biomed Mater Res B Appl Biomater. 2022. PMID: 35384274 Free PMC article.
-
Decellularized Extracellular Matrices for Skin Wound Treatment.Materials (Basel). 2025 Jun 12;18(12):2752. doi: 10.3390/ma18122752. Materials (Basel). 2025. PMID: 40572885 Free PMC article. Review.
-
Case Report: Freeze-Dried Human Amniotic Membrane Allograft for the Treatment of Chronic Wounds: Results of a Multicentre Observational Study.Front Bioeng Biotechnol. 2021 Jun 24;9:649446. doi: 10.3389/fbioe.2021.649446. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34249879 Free PMC article.
-
Healing of diabetic foot ulcer with topical and oral administrations of herbal products: A systematic review and meta-analysis of randomized controlled trials.Int Wound J. 2024 Feb;21(2):e14760. doi: 10.1111/iwj.14760. Int Wound J. 2024. PMID: 38356150 Free PMC article.
References
-
- WHO . Top 10 causes of death: Global Health Observatory (GHO) data, 2016. Geneva, Switzerland. https://www.who.int/gho/mortality_burden_disease/causes_death/top_10/en/.
-
- Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271‐281. - PubMed
-
- James SLG, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990‐2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789‐1858. - PMC - PubMed
-
- Grennan D. Diabetic foot ulcers. JAMA. 2019;321(1):114. - PubMed
-
- IDF . International Diabetes Federation. Diabetes Atlas 8th Edition, 2017. https://diabetesatlas.org/.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical